G3



Trademark Coverage

No Class Specified

Diagnostic and testing kits comprised of reagents for characterizing and quantifying nucleic acids for staging and grading in prostate cancer, namely, gene expression, copy number variation or sequence variations

Owner

GenomeDx Biosciences Inc.

Business in Vancouver, BC, CA

Owns 20 trademarks

Timeline
  • Oct 18
    2013
    Abandonment Notice Mailed Failure To Respond
  • Oct 18
    2013
    Abandonment Failure To Respond Or Late Response
  • Mar 22
    2013
    Notification Of Non Final Action E Mailed
  • Mar 22
    2013
    Non Final Action E Mailed
  • Mar 22
    2013
    Non Final Action Written
  • Mar 22
    2013
    Assigned To Examiner
  • Dec 14
    2012
    Notice Of Pseudo Mark Mailed
  • Dec 13
    2012
    New Application Office Supplied Data Entered In TRAM
  • Dec 07
    2012
    New Application Entered In TRAM